EQRx, Inc.
EQRXDelisted Nov 9, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001843762
EQRx, Inc. was delisted on Nov 9, 2023; its insiders filed their last Form 4 on Nov 14, 2023; 132 institutions reported holding it in 13F filings for Q3 2023, worth $768.6M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in EQRx, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 90
- +25 vs. Q4 2021
- Shares held
- 339.4M
- +18.0M (+5.6%) vs. Q4 2021
- Total value
- $1.40B
- −$786.7M (−36.0%) vs. Q4 2021
- New holders
- 36
- 19 more added
- Sold out
- 11
- 8 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EQRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 132 | $768.6M |
| Q2 2023 | 123 | $659.1M |
| Q1 2023 | 116 | $689.7M |
| Q4 2022 | 109 | $877.5M |
| Q3 2022 | 119 | $1.91B |
| Q2 2022 | 109 | $1.70B |
| Q1 2022 | 90 | $1.40B |
| Q4 2021 | 65 | $2.18B |
| Q3 2021 | 75 | $377.9M |
| Q2 2021 | 32 | $185.9M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding EQRx, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Koshinski Asset Management, Inc. | 0 | $0 | 0.00% | −300−100.0% | Sold out |